COMMUNIQUÉS West-GlobeNewswire

Scythian Announces ABP S.A.’s First Purchase Order with Aphria Inc.

18/04/2018 - 15:02

– Order to Supply World Renowned Pediatric Hospital for Research and Education – TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) ( [...]

Genocea Presents Data at AACR Annual Meeting Further Highlighting Advantages of ATLAS Platform in Identification of Neoantigens over in silico Methods

18/04/2018 - 15:01

- ATLAS data demonstrate in silico methods miss most empirically confirmed neoantigens - - ATLAS able to identify inhibitory neoantigens - - Mouse ATLAS melanoma model developed to study mechanism of inhibitory antigens [...]

OncoMed Presents Multiple Preclinical Abstracts Related to Immuno-Oncology Programs at the 2018 American Association for Cancer Research Annual Meeting

18/04/2018 - 15:01

REDWOOD CITY, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ: OMED ), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]

Ogilvy CommonHealth Worldwide’s Goss and Sherman tapped to present at 2018 DTC National Conference

18/04/2018 - 15:00

PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced Catherine Goss, SVP, managing [...]

New Data Shows Biodesix Blood Test Reliably Detects Additional Mutations in Patients with NSCLC

18/04/2018 - 15:00

Highly multiplexed ddPCR-based assay currently in use by biopharma partners BOULDER, Colo., April 18, 2018 (GLOBE NEWSWIRE) -- Biodesix ® , Inc. is presenting new data today demonstrating the ability of the company’s [...]

AXIM Biotech Files Patent Application on Product Formulation Comprised of Cannabinoids With Anti-Bacterial and Anti-Fungal Activities

18/04/2018 - 15:00

NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (AXIM ® Biotech ), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the European Patent Office (EPO) has [...]

Checkpoint Therapeutics Reports Preclinical Data on BET Inhibitor CK-103 at the American Association for Cancer Research Annual Meeting

18/04/2018 - 15:00

Data support the commencement of a first-in-human Phase 1 trial NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology [...]

Mydx Announces 2017 Fiscal Year Results

18/04/2018 - 15:00

Gross Profit Margin Surged to 73% with Gross Profits Remaining Relatively Flat at ~$306K as MyDx Continues to Execute on its Long-Term Strategy SAN DIEGO, CA , April 18, 2018 (GLOBE NEWSWIRE) -- MyDx, Inc. ( OTC: MYDX [...]

TG Therapeutics, Inc. Announces Preclinical Data Presentation on the Company’s BET Inhibitor, TG-1601, at the 2018 American Association for Cancer Research (AACR) Annual Meeting

18/04/2018 - 15:00

NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today announced preclinical data for TG-1601, the Company’s novel BET inhibitor at the American Association for Cancer Research (AACR) [...]

BioPorto appoints Ole Larsen as CFO

18/04/2018 - 14:52

April 18, 2018 Announcement no. 9 Ole Larsen, Executive Vice President & CFO of Bavarian Nordic, will as of June 1, 2018, join BioPorto as the new Chief Financial Officer. In 2008, Ole Larsen joined Bavarian Nordic [...]

CV Sciences, Inc. Announces Silver Level Sponsorship of the 15th Annual Nutrition and Health Conference in Boston, Massachusetts - April 29-May 2, 2018

18/04/2018 - 14:45

Company Continues its Expansion into the Healthcare Professional Market through One-on-One Education, Exclusive Product Offerings and Enhanced Practitioner Support. LAS VEGAS, April 18, 2018 (GLOBE NEWSWIRE) -- CV [...]

Marrone Bio Innovations, Inc. Announces Pricing of Its Common Stock Offering

18/04/2018 - 14:45

DAVIS, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (or "the Company"), a leading provider of bio-based pest management and plant health products for the agriculture, turf and [...]

Teladoc to Announce First Quarter 2018 Financial Results

18/04/2018 - 14:35

PURCHASE, NY, April 18, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, announced today that it will release first quarter 2018 [...]

Origin Successfully Achieves Phase IIb GENESIS Trial Objectives Ahead of Schedule and Announces Early Termination of Study

18/04/2018 - 14:30

PRINCETON, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Origin, Inc., a Phase IIb clinical-stage biotechnology company, today announced that the US Food and Drug Administration has approved its request to conclude patient [...]

Alder BioPharmaceuticals® to Present New Phase 3 Migraine Prevention Data for Eptinezumab at the 70th Annual American Academy of Neurology Meeting

18/04/2018 - 14:30

PROMISE 2 Phase 3 study selected for Emerging Science clinical trials plenary presentation session on April 24, 2018 BOTHELL, Wash., April 18, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a [...]

Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US

18/04/2018 - 14:30

Agreement with BJC Healthcare Covers Both of the Company’s Thyroid Tests PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully [...]

Histogenics Corporation Announces the Appointment of Susan Washer to Its Board of Directors

18/04/2018 - 14:30

Experienced Life Sciences Executive to Serve as Member of Histogenics Board of Directors WALTHAM, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the [...]

INSYS Therapeutics to Advance Clinical Research of Dronabinol Inhalation Using Novel Breath-Actuated Device

18/04/2018 - 14:30

PHOENIX, April 18, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]

Ceapro Inc. Announces Important Collaboration with Prestigious Montreal Heart Institute

18/04/2018 - 14:05

- Beta-glucan project expected to be Ceapro’s first clinical project led by MHI’s Montreal Health Innovations Coordinating Center (MHICC) - EDMONTON, ALBERTA, April 18, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO [...]